Back to catalogue
№ 417 22 filings · 2021-09-14 → 2026-09-11

TRAINLINE PLC

TRN
Travel and Leisure Share price 218p Market cap £733m Overall fit 455 /1000

Partial fit for the strategy: strong operating leverage, fair-to-cheap valuation and fortress balance sheet, but only marginal AI-receiver exposure (platform mentions AI partnerships but no demonstrable AI-driven revenue line). Regulatory overhang caps the upside until GBR path clarifies.

Fair value range 240p–320p Mid case · £943m
Absolute upside +28.7% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Clean reporting with 3-yr track record of guidance upgrades
  • Two methodologies converge on 240-320p range
  • Transparent operating leverage mechanics
Limits the call
  • GBR retail outcome is binary and unknowable
  • CMA fee-presentation probe outcome unquantified
Methodology

Blended P/E (11-14x FY27 adj EPS) and EV/EBITDA (6.5-8.5x FY27 guided EBITDA)

In one line · bull case

Cash-generative European rail aggregator with real operating leverage, fortress balance sheet and aggressive capital return, trading on ~10x adj EPS and ~15% FCF yield because UK regulatory risk is priced in near a worst-case outcome.

In one line · biggest risk

A hostile GBR retail outcome and/or adverse CMA fee-presentation ruling could structurally compress UK Consumer's ~£200m revenue base and permanently reset the multiple lower.

Drivers
AI beneficiary 32 /100
Platform mentions AI Travel Assistant and OpenAI partnership but no quantified AI-driven revenue uplift; Google AI referral is defensive distribution, not AI monetisation.
Operating leverage 72 /100
FY25 revenue +12% drove Adj EBITDA +30% and operating profit +54%; EBITDA/NTS margin stepped from 1.9% to guided 2.9% across four years on fixed-cost Platform One.
Earnings vs expectations 68 /100
Three consecutive years of upgrades (FY24, FY25, FY26 all beat initial guidance); FY27 reconfirmed rather than raised but no miss.
Growth momentum 42 /100
FY27 guided NTS and revenue roughly flat (Group NTS flat, revenue -1% in H1 FY27); UK commission cut and CMA headwinds offsetting European liberalisation tailwinds.
Moat 52 /100
Aggregator network effects strongest in liberalised European markets; UK moat under regulatory and TOC self-preferencing pressure.
Earnings quality 75 /100
£110m operating FCF on £159m EBITDA (FY25), consistent cash conversion, negative working capital model, no exceptional accounting red flags.
Management quality 72 /100
Credible guidance track record, £350m shares repurchased since 2023, candid on regulatory risks and clear capital-allocation framework.
Cyclicality 40 /100
UK commuter base is defensive but International Consumer and B2B travel sensitive to broader travel/economic cycle; rail somewhat more defensive than air.
Leverage 18 /100
Net debt £83m at FY25 (0.5x EBITDA); convertible repaid Jan 2026; likely near net cash now while running £100m buyback programme.
Value-trap signals · 3
  • UK Consumer revenue declining (FY26 -2%, H1 FY27 -5%)
  • Regulatory overhang (GBR retail nationalisation risk, CMA fee-presentation investigation)
  • Growth decelerating from +12% (FY25) to flat (FY27 guide)

TRAINLINE PLC (TRN) — Investment Research Note

Executive summary

Trainline is the leading independent rail/coach ticket aggregator in the UK and continental Europe, running a capital-light platform (Platform One) that sold ~£5.9bn of net ticket sales in FY2025 across UK Consumer, International Consumer and Trainline Solutions. Across the filings the trajectory moved from COVID collapse through a strong three-year rebound (FY25 NTS +12%, Adj EBITDA +30%, OpFCF £110m, EPS +80%), but has flattened into FY2027 (H1 FY27 Group NTS flat, Underlying Revenue −1%), as UK regulatory and competitive headwinds (TOC self-preferencing, Project Oval, commission cut) bite and a CMA investigation into fee presentation opened in August 2026. The single most important valuation point today: at ~£706m market cap the stock trades on 4x FY27 guided Adj EBITDA (£180m) and ~10x adjusted earnings while generating ~£110m+ operating free cash flow and returning capital aggressively — the question is whether the regulatory overhang (GBR retail, CMA) warrants the discount.

Fair value estimate

Range: 240p – 320p per share → implied market cap £810m – £1,078m (vs. current £705.7m).

Methodology — triangulation of two approaches:

  1. EV/EBITDA multiple on FY27 guidance. FY27 Adj EBITDA at the midpoint of 2.9% of £6.3bn NTS = ~£183m. Applying 6.5x – 8.5x (discounted versus comparable travel platforms for GBR/CMA/commission-cut overhang) = EV £1,190m – £1,555m. Deduct ~£83m net debt (likely near zero now post-convertible repayment in Jan 2026) → equity ~£1,110m – £1,470m. Per share 329p – 436p.
  2. P/E on adjusted EPS. FY25 adj. EPS was 19.2p; after a flat FY27 but ~15% further share-count shrink from buybacks, FY27 adj EPS likely 22-24p. Apply 11x – 14x (modest for a cash-generative platform; captures regulatory risk discount) → 242p – 336p per share.

Blending both and leaning toward the P/E range to reflect regulatory risk, I anchor 240p–320p, midpoint ~280p / ~£943m mcap.

Upside at 209p: midpoint implies +34%; low +15%; high +53%.

Sector context

Classification confirmed: Consumer Discretionary / Travel & Leisure. Trainline sits in online travel distribution and is best compared with asset-light travel aggregators (OTAs). On profile:

  • Quality: above-sector average (software margins, negative working capital, fortress balance sheet, high FCF conversion).
  • Growth: in-line to below sector right now given UK headwinds; stronger optionality in Europe.
  • Leverage: well below sector average (net debt 0.5x EBITDA at FY25; convertible repaid Jan 2026).

Listed comparables: Booking Holdings (BKNG), eDreams ODIGEO (EDR), lastminute.com (LMN). More spiritually, European rail/mobility platforms like GoAhead or incumbent transport operators (FirstGroup, Mobico), though Trainline is a pure-play tech platform rather than an operator.

Investment thesis (3 bullets)

  • Deep operating leverage on recovering European liberalisation. Trainline Solutions B2B International grew +45% YoY in H1 FY27 and South-East France +26% in FY26 as Trenitalia expands; the EU addressable high-speed market is projected to grow from ~€17bn to €23bn by 2030, with liberalisation in France, Italy following Spain's playbook (NTS in Spain nearly tripled in two years). Fixed-cost platform means incremental European NTS converts at high contribution margin 2025-05 FY25 Final Results; 2026-09 H1 trading statement.
  • Cash-return engine funded by durable UK cash flows. Since Sept 2023 Trainline has repurchased £350m of shares (28% of issued capital at programme start), announced a further £100m programme in Sept 2026, repaid its £82.7m convertible bond in Jan 2026, and generated £110m operating FCF in FY25 at 2.69% EBITDA/NTS, rising to a guided 2.9% in FY27. Net debt was £83m (0.5x) at FY25 and is likely around zero now 2025-05 FY25; 2026-09 H1 trading; 2026-03 FY26 trading.
  • Priced for regulatory worst case, not base case. The stock is down 23% YoY and trades on ~4x FY27 EBITDA / ~10x adj. EPS / ~15% FCF yield while management reconfirmed FY27 revenue/EBITDA/NTS guidance in Sept 2026. Base case does not require Europe to re-rate the stock; it requires the GBR retail risk not to crystallise destructively — Government rhetoric in the Feb 2025 Railways Bill consultation explicitly committed to "fair, open and competitive" retail market with CMA-supported level-playing-field safeguards 2025-05 FY25 Final Results; 2026-09 H1 trading statement.

Key risks (3 bullets)

  • GBR nationalised retail & TOC self-preferencing. Even without legislation, UK TOCs are already promoting features (1-click delay-repay) that third-party retailers are expressly prohibited from offering; Project Oval expansion puts an estimated c.£150m of UK Consumer NTS at risk. A hostile GBR retail outcome could structurally compress UK Consumer's ~£204m revenue base 2026-03 FY26 trading statement; 2025-05 FY25 Final Results.
  • CMA investigation into UK fee presentation (opened Aug 2026). Early-stage but financial outcome is unquantifiable; underlying revenue reporting now excludes "any potential non-recurring revenue adjustments" from this process, signalling management expects a possible financial hit 2026-09 H1 trading statement.
  • Google / search traffic erosion compounded by LLM shift. International Consumer foreign-travel sales have been pressured by Google search page changes for two consecutive years; while management now cites being the "number one recommended rail aggregator in Google AI", heavy dependence on third-party distribution channels is a structural risk — not disclosed as revenue line item but inferred from repeated references to search-page impact across FY24-FY26 filings 2024-05 FY24 Final Results; 2026-03 FY26 trading; 2026-09 H1 trading.

Operating leverage

Trainline is a textbook high-fixed-cost platform business. Of FY25's £266.7m administrative-expense base, marketing (£70.9m) and other administrative expense (£122.3m) scale slower than revenue, and the £43m D&A plus £119m three-year capex is predominantly fixed R&D on Platform One. Gross margin in FY25 was 80% (£352m gross profit on £442m revenue). Adj EBITDA as a % of NTS has stepped up every year — 1.9% (FY23) → 2.31% (FY24) → 2.69% (FY25) → guided 2.9% (FY27) — illustrating that when revenue grows, operating profit grows ~2-3x faster (FY25: revenue +12%, Adj EBITDA +30%, operating profit +54%). On a 10-20% upside revenue surprise versus FY27 guidance (£490m revenue vs ~£447m), I would estimate incremental Adj EBITDA contribution margin at 55-65%, implying £24-28m of additional EBITDA, i.e. operating profit uplift of ~30-40%. The inflection points are visible: digital-rail scale economics (UK), European aggregation playbook as new carriers arrive, and B2B Global API where international NTS grew +58% in FY25 and +45% in H1 FY27 — this is capacity-light growth 2025-05 FY25; 2026-03 FY26 trading; 2026-09 H1 trading.

Value-trap signals

  • UK Consumer revenue is flat-to-down (FY26: -2% YoY; H1 FY27: -5% YoY) despite NTS growth, due to the April 2025 commission-rate cut (5.0% → 4.5%) and mix shift to shorter-distance travel.
  • Regulatory overhang is real and multi-pronged (GBR retail, CMA investigation, TOC self-preferencing, Project Oval).
  • International Consumer H1 FY27 NTS declined -4% YoY on Spanish accident fallout and softer foreign travel — the European thesis is not uniformly on-trend.
  • Group NTS flat and underlying revenue -1% in H1 FY27 is a meaningful deceleration from the +22%/+12% growth in FY24/FY25.

These are real headwinds, but the balance sheet, cash generation, buyback trajectory and no dividend-cut history argue against classic value-trap signals (no debt stress, no going-concern language, no restatements, no related-party issues, no customer concentration >10%, no terminal-decline industry).

Earnings vs. expectations

Across the filings, the pattern is more beats than misses. In FY25, management repeatedly upgraded guidance: Sept 2024 trading update raised Adj EBITDA guidance above the previous range; March 2025 trading statement confirmed delivery marginally ahead of the upgraded guidance; final FY25 results delivered Adj EBITDA £159m (+30%) vs. a prior guidance band that implied low-20s% growth. In Sept 2025 management again upgraded FY26 Adj EBITDA growth to top-end of the range (+10-13%), and in March 2026 confirmed delivery "in line with enhanced expectations". FY27 is the first year since COVID where guidance is being reconfirmed rather than upgraded (Sept 2026 statement), reflecting the UK commission cut and CMA headwind rather than an operational miss. Three consecutive years of upgrades suggests credible, conservative management guidance; the stabilisation in FY27 is a watch-point not a red flag.

Conviction

Rating: 3 (moderate).

Anchoring factors: (a) clean, consistently reported financials with multi-year track record of guidance beats; (b) simple business model with clear operating leverage mechanics visible in the data; (c) two independent valuation methodologies (P/E and EV/EBITDA) converging on a 240-320p range materially above current price.

Limiting factors: (a) GBR regulatory outcome is binary and genuinely unknowable from the filings — any central valuation must apply a wide discount for this; (b) CMA investigation adds a near-term uncertain financial impact that management is unwilling to quantify.

Overall score rationale

Trainline fits the "fair price, good operating leverage, strong balance sheet" pillars of the portfolio brief, but is weak on direct AI-receiver exposure — it is a platform user of AI, not a seller into the AI buildout. The valuation discipline is attractive (not priced for perfection, visible margin of safety on cash flow and buybacks), operating leverage is clearly demonstrated, and downside protection is adequate (net cash position, 75-80% FCF conversion). The AI angle is weak, so this is a partial fit rather than a top-band buy.

Filings consulted · 22

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-11Trading Statement And Notice OF Half Year Results2026-09-11_9766666_trading-statement-and-notice-of-half-year-results.md0.90
  2. 2026-06-18Result OF Agm2026-06-18_9626166_result-of-agm.md0.30
  3. 2026-03-12Trading Statement And Notice OF Full Year Results2026-03-12_9470253_trading-statement-and-notice-of-full-year-results.md0.85
  4. 2025-09-11Trading Statement And Notice OF Half Year Results2025-09-11_9100536_trading-statement-and-notice-of-half-year-results.md0.58
  5. 2025-06-26Result OF Agm2025-06-26_8950297_result-of-agm.md0.20
  6. 2025-05-07Final Results2025-05-07_8864028_final-results.md0.65
  7. 2025-03-13Trading Statement And Notice OF Full Year Results2025-03-13_8776762_trading-statement-and-notice-of-full-year-results.md0.65
  8. 2024-09-12Trading Statement And Notice OF Half Year Results2024-09-12_8412409_trading-statement-and-notice-of-half-year-results.md0.41
  9. 2024-06-27Result OF Agm2024-06-27_8282116_result-of-agm.md0.14
  10. 2024-05-03Final Results2024-05-03_8172258_final-results.md0.45
  11. 2024-03-14Trading Statement2024-03-14_8086813_trading-statement.md0.38
  12. 2024-03-06Notice OF Fy2024 Trading Update2024-03-06_8073692_notice-of-fy2024-trading-update.md0.38
  13. 2023-09-14Trading Statement2023-09-14_7754347_trading-statement.md0.21
  14. 2023-09-01Notification OF Half Year Trading Update Amp Results2023-09-01_7729337_notification-of-half-year-trading-update-amp-results.md0.23
  15. 2023-06-29Result OF Agm2023-06-29_7603481_result-of-agm.md0.07
  16. 2023-05-04Final Results2023-05-04_7511959_final-results.md0.25
  17. 2023-03-15Trading Statement And Notice OF Full Year Results2023-03-15_7436424_trading-statement-and-notice-of-full-year-results.md0.25
  18. 2022-09-15Trading Statement And Notice OF Half Year Results2022-09-15_7316217_trading-statement-and-notice-of-half-year-results.md0.23
  19. 2022-07-06Trading Update2022-07-06_6873553_trading-update.md0.21
  20. 2022-06-30Result OF Agm2022-06-30_7151263_result-of-agm.md0.07
  21. 2022-03-17Trading Statement And Notice OF Full Year Results2022-03-17_6968384_trading-statement-and-notice-of-full-year-results.md0.25
  22. 2021-09-14Trading Statement And Notice OF Half Year Results2021-09-14_6825444_trading-statement-and-notice-of-half-year-results.md0.09

This research note was authored by a large language model after reading 22 regulatory filings published between 2021-09-14 and 2026-09-11. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.